Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

Conditions: Epithelial Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer
Interventions: Drug: entinostat; Drug: avelumab; Drug: Placebo
Sponsors: Syndax Pharmaceuticals; Merck KGaA, Darmstadt, Germany; Pfizer
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 12, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments